Johnson & Johnson Single-Shot COVID-19 Vaccinations to Resume in the U.S. for All Adults Aged 18 and Older Following CDC and FDA Decision
NEW BRUNSWICK, N.J., April 23, 2021 – Johnson &Johnson (NYSE: JNJ) (the Company) today announced that vaccinations with the Company’s COVID-19 single-shot vaccine will resume for all adults aged 18 years and older in the U.S., under Emergency Use Authorization (EUA), following a decision from the United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA).The decision was based on a recommendation from the U.S. CDC Advisory Committee on Immunization Practices (ACIP), which followed a rigorous evaluation of data relating to a very rare adverse event involving blood clots in combination with low platelet counts (thrombosis with thrombocytopenia) observed within approximately one to two weeks following vaccination. “As the global pandemic continues to devastate communities around the world, we believe a single-shot, easily transportable COVID-19 vaccine with demonstrated protection against multiple variants can help protect the health and safety of people everywhere. We will collaborate with health authorities around the world to educate healthcare professionals and the public to ensure this very rare event can be identified early and treated effectively,” said Paul Stoffels, Chief Scientific Officer of Johnson &Johnson.Johnson &Johnson has updated the EUA Fact Sheets for Healthcare Providers Administering Vaccine (Vaccination Providers), and Recipients and Caregivers for the Company’s COVID-19 vaccine, to incl...
Abe Oudshoorn, Tanya Benjamin, Tracy A. Smith-Carrier, Sarah Benbow, Carrie Anne Marshall, Riley Kennedy, Jodi Hall, C. Susana Caxaj, Helene Berman, Deanna Befus Housing, Care and Support, Vol. ahead-of-print, No. ahead-of-print, pp.- People experiencing homelessness are uniquely vulnerable to the impacts of a pandemic, such as COVID-19. Therefore, governments across Canada have been implementing a patchwork of responses to address the needs of those who are homeless at this time. The purpose of this study is to both compile and assess the varying responses by exploring the breadth of actions presented i...
ConclusionPort-a-cath placement in pediatric patients with OI is safe and efficacious for durable central access, enabling reliable IV bisphosphonate delivery and reducing iatrogenic trauma.
ConclusionThe national birth prevalence for omphalocele in Sweden is 1/10,000 newborn, with high termination rates. Over half of the pregnancies with prenatally diagnosed omphalocele will be terminated. Among those who continue the pregnancy, 1-year survival rates are high.Type of studyNational register studyLevel of evidenceIII.
ConclusionIn the follow-up of children and adolescents with CCM during the first UK lockdown using telemedicine we found that over half had stable health conditions. Patients needing additional care could not be predicted by the severity of their disease or their bowel function alone.
A new"rapid expert consultation" has identified"actionable guidance" that state and local decision-makers can use to communicate with the public.Medscape Medical News
At Legacy, fewer than 500 employees are not vaccinated.
After a Covid-19-related delay, UNC Rex Healthcare has announced its new hospital in Holly Springs will open Nov. 1.
Puerto Rico's rate tops all states and territories. One expert thinks it may in large part be due to not tying vaccine beliefs to politics.Medscape Medical News
As the COVID-19 vaccine heads toward approval for children under age 12 years, the number of older children receiving it dropped for the 10th consecutive week.Medscape Medical News
More News: African Health | Allergy & Immunology | Biotechnology | Bleeding | Brain | Brazil Health | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Coronavirus | COVID-19 | Education | Emergency Medicine | Environmental Health | Food and Drug Administration (FDA) | Headache | Health and Safety | Health Management | Heart | Hematology | Hospitals | Hypertension | Infectious Diseases | Learning | Legislation | Men | Migraine | Neurology | Neuroscience | Pain | Pain Management | Pandemics | Pharmaceuticals | Pregnancy | Pulmonary Hypertension | Pulmonary Thromboembolism | Respiratory Medicine | SARS | Science | Skin | South Africa Health | Study | Thrombocytopenia | Thrombosis | Universities & Medical Training | USA Health | Vaccines